| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MDS.22759 |
| P698 | PubMed publication ID | 19908302 |
| P50 | author | Robert A Hauser | Q64855796 |
| David Oakes | Q67209506 | ||
| Parkinson Study Group | Q98686625 | ||
| P2093 | author name string | Peggy Auinger | |
| P2860 | cites work | Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology | Q30793529 |
| Treatment of Parkinsonism With Levodopa | Q34240368 | ||
| A clinicopathologic study of 100 cases of Parkinson's disease | Q36776426 | ||
| Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics | Q43993953 | ||
| Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases | Q44083170 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| levodopa | Q300989 | ||
| P304 | page(s) | 2328-2336 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Levodopa response in early Parkinson's disease | |
| P478 | volume | 24 |
| Q37267591 | Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes |
| Q34027880 | Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease |
| Q36642364 | Cortical and motor responses to acute forced exercise in Parkinson's disease |
| Q30417007 | Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. |
| Q33623531 | Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression |
| Q28486256 | Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa |
| Q96348445 | Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease |
| Q39094808 | Integrating Patient Concerns into Parkinson's Disease Management |
| Q35183563 | Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. |
| Q37677170 | New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy |
| Q41168222 | Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease |
| Q89769611 | The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review |
| Q38099197 | The role of neuroplasticity in dopaminergic therapy for Parkinson disease. |
| Q38358021 | The sensitivity and specificity of F-DOPA PET in a movement disorder clinic |
Search more.